The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancer

被引：0
|
作者：
Goro Nakayama
Chie Tanaka
Keisuke Uehara
Naoki Mashita
Naomi Hayashi
Daisuke Kobayashi
Mitsuro Kanda
Suguru Yamada
Tsutomu Fujii
Hiroyuki Sugimoto
Masahiko Koike
Shuji Nomoto
Michitaka Fujiwara
Yuich Ando
Yasuhiro Kodera
机构：
[1] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery (Surgery II)
[2] Nagoya University Graduate School of Medicine,Department of Surgical Oncology (Surgery I)
[3] Nagoya University Hospital,Department of Clinical Oncology and Chemotherapy
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Colorectal cancer; Relative dose intensity; Dose index; Time index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：847 / 855
页数：8
相关论文
共 50 条
  • [31] Oxaliplatin-based chemotherapy in the management of colorectal cancer
    Capdevila, Jaume
    Elez, Elena
    Peralta, Sergio
    Macarulla, Teresa
    Javier Ramos, Francisco
    Tabernero, Josep
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (08) : 1223 - 1236
  • [32] Impact of Irinotecan and Oxaliplatin on Overall Survival in Patients With Metastatic Colorectal Cancer: A Population-Based Study
    Lim, Howard J.
    Gill, Sharlene
    Speers, Caroline
    Melosky, Barbara
    Barnett, Jeff
    Fitzgerald, Catherine
    O'Reilly, Susan
    Kennecke, Hagen
    JOURNAL OF ONCOLOGY PRACTICE, 2009, 5 (04) : 153 - 158
  • [33] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    Alliot, C
    Barrios, M
    BRITISH JOURNAL OF CANCER, 2004, 90 (10) : 2050 - 2051
  • [34] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    T Aparicio
    J Desramé
    T Lecomte
    E Mitry
    J Belloc
    I Etienney
    S Montembault
    L Vayre
    C Locher
    J Ezenfis
    P Artru
    M Mabro
    S Dominguez
    British Journal of Cancer, 2003, 89 : 1439 - 1444
  • [35] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    Aparicio, T
    Desramé, J
    Lecomte, T
    Mitry, E
    Belloc, J
    Etienney, I
    Montembault, S
    Vayre, L
    Locher, C
    Ezenfis, J
    Artru, P
    Mabro, M
    Dominguez, S
    BRITISH JOURNAL OF CANCER, 2003, 89 (08) : 1439 - 1444
  • [36] Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
    C Alliot
    M Barrios
    British Journal of Cancer, 2004, 90 : 2050 - 2051
  • [37] Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study
    Chibaudel, Benoist
    Bonnetain, Franck
    Tournigand, Christophe
    Bengrine-Lefevre, Leila
    Teixeira, Luis
    Artru, Pascal
    Desrame, Jerome
    Larsen, Annette K.
    Andre, Thierry
    Louvet, Christophe
    de Gramont, Aimery
    ONCOLOGIST, 2011, 16 (09): : 1228 - 1238
  • [38] Drug use evaluation of oxaliplatin and irinotecan in metastatic colorectal cancer
    Llopis-Salvia, Pilar
    Sarrio-Montes, Gema
    Sanchez-Castellon, Agueda
    PHARMACY WORLD & SCIENCE, 2009, 31 (01): : 138 - 138
  • [39] Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer
    Ohhara, Yoshihito
    Suenaga, Mitsukuni
    Matsusaka, Satoshi
    Shinozaki, Eiji
    Mizunuma, Nobuyuki
    Yamaguchi, Toshiharu
    ONCOTARGETS AND THERAPY, 2015, 8 : 529 - 537
  • [40] Incidence of Cold-Induced Peripheral Neuropathy and Dose Modification of Adjuvant Oxaliplatin-Based Chemotherapy for Patients with Colorectal Cancer
    Altaf, Rahim
    Brixen, Annette Lund
    Kristensen, Bent
    Nielsen, Svend Erik
    ONCOLOGY, 2014, 87 (03) : 167 - 172
12345